Diabetic peripheral neuropathies: Their cost to patient and society and the value of knowledge of risk factors for development of interventions

European Neurology

Volumn 41, Issue SUPPL. 1, 1999, Pages 35-43

  Thomas, Peter K ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cost of illness; Diabetic neuropathy; Disease progression; Epidemiology; Peripheral nerve diseases; Risk factors

Indexed keywords

RECOMBINANT NERVE GROWTH FACTOR;

AUTONOMIC NERVOUS SYSTEM; CONFERENCE PAPER; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE COURSE; FOOT; HUMAN; LEG AMPUTATION; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; NERVE FUNCTION; POLYNEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SENSORY NERVE; UNITED STATES;

EID: 0033023531     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052078     Document Type: Conference Paper

References (62)

1. Watkins PJ, Thomas PK: Diabetes mellitus and the nervous system. J Neurol Neurosurg Psychiatry 1998;65:620-632.
2. Pirart J: Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Metab 1977;3:97-107;173-182;245-256.
3. Watkins PJ: The natural history of the diabetic neuropathies. Q J Med 1990;77:1209-1218.
4. Guy RJC, Clark CA, Malcolm PN, Watkins PJ: Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia 1985;28: 131-137.
5. Boulton AJM, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM, Skyler JS, Sosenko JM: Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986; 3:335-337.
6. Young MJ, Manes C, Boulton AJM: Vibration perception threshold predicts foot ulceration. Diabet Med 1992;9(suppl 2):542.
7. Boulton AJM, Hardisty CA, Betts RP, Franks CI, Worth RC, Ward JD, Duckworth T: Dynamic foot pressures and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983;6:26-33.
8. Edmonds ME: Experience in a multi-disciplinary diabetic foot clinic; in Connor H, Boulton AJM, Ward JD (eds): Foot in Diabetes, ed 1. Chichester, Wiley, 1987, pp 121-133.
9. Thomson F, Veves A, Ashe H, Knowles EA, Gem J, Walker MG, Hirst P, Boulton AJM: A team approach to diabetic foot care: The Manchester experience. Foot 1991;1:75-82.
10. Sosenko JM, Kato M, Soto R, Bild DE: Comparison of quantitative sensory test measurements and their association with foot ulceration in diabetic patients. Diabetes Care 1990; 13:1057-1061.
11. Rith-Najarian SJ, Stolusky T, Ghodes DM: Identifying patients at high risk for lower extremity amputation in a primary health care setting. Diabetes Care 1992;15:1386-1389.
12. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M: Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998;20:169-181.
13. Stevens MJ, Edmonds ME, Foster AVM, Watkins PJ: Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 1992;35:148-152.
14. Cundy TF, Edmunds ME, Watkins PJ: Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 1985;2:461-473.
15. Brower AC, Allman RM: Pathogenesis of the Neurotrophic joint: Neurotraumatic vs neurovascular. Radiology 1981;139:349-354.
16. Sanders LJ, Frykberg RG: Diabetic neuropathic osteoarthropathy: The Charcot foot; in Frykberg RG (ed): The High Risk Foot in Diabetes. New York, Churchill Livingstone, 1991, pp 227-238.
17. Cavanagh PR, Young MJ, Adams DE, Vickers KL, Boulton AJM: Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994;17:201-209.
18. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95-108.
19. Sampson MJ, Wilson S, Karagianis P, Edmunds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990;15: 635-646.
20. Guy RJC, Dawson LJL, Garrett JR, Laws JW, Thomas PK, Sharma AK: Diabetic gastroparesis from autonomic neuropathy: Surgical considerations and changes in vagus nerve morphology. J Neurol Neurosurg Psychiatry 1984; 47:696-691.
21. Rubin A, Babbot D: Impotence and diabetes. JAMA 1958;168:498-500.
22. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J: The natural history of acute painful diabetic neuropathy. J Neurol Neurosurg Psychiatry 1983;46:491-499.
23. Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P: Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol 1986;72:157-163.
24. Castellanos F, Mascias J, Zabala JA, Ricart C, Cabello A, Garcia-Merino A: Acute painful diabetic neuropathy following severe weight loss. Muscle Nerve 1996;19:363-367.
25. Stewart JD: Diabetic truncal neuropathy: Topography of the sensory defect. Ann Neurol 1989;25:233-238.
26. Boulton AJM, Angus E, Ayyar DR, Weiss R: Diabetic thoracic polyradiculopathy presenting as an abdominal swelling. Br Med J 1984;289: 798-800.
27. Parry GJ, Floberg J: Diabetic truncal neuropathy presenting as an abdominal hernia. Neurology 1989;39:1488-1490.
28. Chaudhuri KP, Wren DR, Werring D, Watkins PJ: Unilateral abdominal muscle herniation with pain: A distinctive variant of diabetic radiculopathy. Diabet Med 1997;14:803-807.
29. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A: Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;35:559-569.
30. Coppack SW, Watkins PJ: The natural history of diabetic femoral neuropathy. Q J Med 1991; 79:307-314.
31. Casey EB, Harrison MJG: Diabetic amyotrophy: A follow-up study. Br Med J 1972;1:656-659.
32. Stewart JD, McKelvey R, Durcan L, Carpenter S, Karpati G: Chronic inflammatory demyclinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 1996;142:59-64.
33. Dyck PJ, Karnes KL, Daube J, O'Brien P, Service FJ: Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985;108:861-880.
34. Dyck PJ: Detection, characterization and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 1988;11:21-22.
35. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ III: The Rochester Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164-1170.
36. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC: Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997;49:229-239.
37. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Calan N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;7:1281-1289.
38. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Path JM, Wilson DM, O'Brien PC, Melton LJ III: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort. Neurology 1993;43:817-824.
39. Mincu I: Micro- and macroangiopathies and other degenerative complications in newly detected diabetes mellitus. Med Interne 1980;18: 15-64.
40. Young MJ, Boulton AJM, McLeod AF, Williams DRR, Sonkscn PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154.
41. Palumbo PJ, Elveback LR, Whisnant JP: Neurological complications of diabetes mellitus: Transient ischaemic attack, stroke, and peripheral neuropathy. Adv Neurol 1978;19:593-601.
42. Bharucha NE, Bharucha AE, Bharucha EP: Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 1991; 41:1315-1316.
43. Savattieri G, Rocca WA, Salemi G, Meneghini F, Grigoletto F, Morgante L, Reggio A, Costa V, Coraci MA, Di-Perri R: Prevalence of diabetic neuropathy with somatic symptoms: A door-to-door survey in two Sicilian municipalities. Neurology 1993;43:1115-1120.
44. Italian General Practitioner Study Group (IGPSG): Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation in two Italian regions. 1. Prevalence and general characteristics of the sample. Neurology 1995;45:1832-1836.
45. Williams DRR: The size of the problem: Epidemiological and economic aspects of foot problems in diabetes: in Boulton AJM, Connor H, Cavanagh PR (eds): The Foot in Diabetes, ed 2. Chichester, Wiley, 1994, pp 15-24.
46. Bessman AN: Foot problems in diabetes. Compr Ther 1982;8:32-37.
47. Kozak GP, Rowbothan JL: Diabetic foot disease: A major problem: in Kozak GP, Hoer CS (eds): Management of Diabetic Foot Problems, Philadelphia, Saunders, 1984, pp 1-8.
48. Reiber GE: Diabetic foot care: Financial implications and practical guidelines. Diabetes Care 1992;15(suppl 1):29-51.
49. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 1989;262: 2708-2713.
50. Most RS, Sinock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91.
51. Ebskov B, Josephson P: Incidence of reamputation and death after gangrene of the lower extremity. Prosthet Orthot Int 1980;4:77-80.
52. Connor H: The economic impact of diabetic foot disease: in Conner H, Boulton AJM, Ward JD (eds): The Foot in Diabetes, Chichester, Wiley, 1986, pp 145-149.
53. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J: Diabetic foot ulcers in a multidisciplinary setting: An economic analysis of primary healing and healing with amputation. J Intern Med 1994;235:463-471.
54. Diabetes Control and Complications Trial Research Group: Factors in the development of diabetic neuropathy: Baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes 1988;37:476-481.
55. Thomas PK, Tomlinson D: Diabetic and hypoglycaemic neuropathy: in Dyck PJ, Thomas PK, Griffin JW (eds): Peripheral Neuropathy, ed 3. Philadelphia, Saunders, 1993, pp 1219-1250.
56. Heeson AE, Millward A, Domaine AG: Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J Neurol Neurosurg Psychiatry 1998;54:213-216.
57. Hellweg R, Hartung HD: Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990;26:258-267.
58. Jakobsen J, Brimijoin S, Sklau K, Sidenius P, Wells D: Retrograde axonal transport of transmitter enzymes, fucose labelled protein and nerve growth factor in streptozotocin diabetic rats. Diabetes 1981;30:797-803.
59. Apfel SC, Lipton RB, Arezzo JC, Kessler JA: Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 1991;29:87-90.
60. Apfel SC, Arezzo JC, Lipson L, Kessler JA: Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992;31:76-80.
61. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA and the NGF Study Group: Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 1998;51:695-702.
62. Rask C, Sanders C, Häussler J: Positive results of phase II recombinant human nerve growth factor (rhNGF) triggers two phase III trials to confirm efficacy and safety in diabetic neuropathy. J Neurol 1998;245:447.